Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA CIL56 CTRPv2 pan-cancer AAC -0.065 0.2
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.062 0.2
mRNA CID-5951923 CTRPv2 pan-cancer AAC -0.053 0.2
mRNA itraconazole CTRPv2 pan-cancer AAC -0.053 0.2
mRNA cimetidine CTRPv2 pan-cancer AAC 0.093 0.2
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC -0.07 0.2
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.049 0.2
mRNA A-804598 CTRPv2 pan-cancer AAC 0.061 0.2
Download CSV